Bukya Sheela, Suryadevara Aparna, Chinta Sanjeeva Kumari, Triveni B
Department of Radiation Oncology, Mehdi Nawaz Jung Institute of Oncology & Regional Cancer Centre, Hyderabad, Telangana India.
Department of Pathology, Mehdi Nawaz Jung Institute of Oncology & Regional Cancer Centre, Hyderabad, Telangana India.
Indian J Surg Oncol. 2021 Jun;12(2):286-289. doi: 10.1007/s13193-021-01324-6. Epub 2021 Apr 19.
Breast cancer (BC) is the most common cancer among Indian women and invasive duct cell carcinoma (IDCC) the most common histology (80-90%) followed by noninvasive duct cell carcinoma (non-IDCC) subtypes (about 10%). Most of the non-IDCC are rare (<1-2%), and literature on this topic is sparse. Age is an important prognostic factor and varies with ethnicity. The aim of our study is to evaluate the incidence and age at presentation of different types of BC.
This is a single institute retrospective observational study evaluating BC over the last 7 years at our institute. We evaluated the demographic and pathological features.
There were a total of 2725 patients, of these 89.7% had IDCC and 10.2% had non-IDCC. There were 13 subtypes of non-IDCC, the most common being sarcoma/phyllodes (2.4%) and lobular (2.3%). The other subtypes were very rare (<1.5% each). The non-IDCC male BC was very rare (0.07%). The median age at presentation was similar for IDCC and non-IDCC types (50 years). The value for age at presentation was significant for mucinous (0.0001), phyllodes (<0.0001), and sarcoma breast (0.009) when compared with IDCC.
The incidence of IDCC, non-IDCC, and rare subtypes of non-IDCC are comparable to literature except lobular (lower) and phyllodes/sarcoma (higher). Indian patients presented a decade earlier for both IDCC and non-IDCC types. Tubular and papillary presented at an age comparable to IDCC, in contrast to the West. Given these differences, the prognosis of non-IDCC needs to be evaluated in future studies on Indian BC patients.
乳腺癌(BC)是印度女性中最常见的癌症,浸润性导管细胞癌(IDCC)是最常见的组织学类型(80 - 90%),其次是非浸润性导管细胞癌(非IDCC)亚型(约10%)。大多数非IDCC类型较为罕见(<1 - 2%),关于这一主题的文献稀少。年龄是一个重要的预后因素,且因种族而异。我们研究的目的是评估不同类型乳腺癌的发病率及发病年龄。
这是一项单机构回顾性观察研究,评估了本机构过去7年的乳腺癌情况。我们评估了人口统计学和病理学特征。
共有2725例患者,其中89.7%为IDCC,10.2%为非IDCC。非IDCC有13种亚型,最常见的是肉瘤/叶状肿瘤(2.4%)和小叶型(2.3%)。其他亚型非常罕见(各<1.5%)。非IDCC男性乳腺癌极为罕见(0.07%)。IDCC和非IDCC类型的发病年龄中位数相似(50岁)。与IDCC相比,黏液性(0.0001)、叶状肿瘤(<0.0001)和乳腺肉瘤(0.009)的发病年龄 值具有显著性。
IDCC、非IDCC以及非IDCC罕见亚型的发病率与文献报道相当,但小叶型(较低)和叶状肿瘤/肉瘤型(较高)除外。印度IDCC和非IDCC类型的患者发病时间比西方早十年。与西方不同,管状和乳头状类型的发病年龄与IDCC相当。鉴于这些差异,未来对印度乳腺癌患者的研究需要评估非IDCC的预后。